Taekyu Lim

607 total citations
14 papers, 470 citations indexed

About

Taekyu Lim is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Taekyu Lim has authored 14 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Cancer Research. Recurrent topics in Taekyu Lim's work include Pancreatic and Hepatic Oncology Research (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Cancer Genomics and Diagnostics (3 papers). Taekyu Lim is often cited by papers focused on Pancreatic and Hepatic Oncology Research (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Cancer Genomics and Diagnostics (3 papers). Taekyu Lim collaborates with scholars based in South Korea and United States. Taekyu Lim's co-authors include Won Ki Kang, Joon Oh Park, Ho Yeong Lim, Young Suk Park, Kee‐Taek Jang, Kyung Kee Baek, Jeeyun Lee, Keunchil Park, Boram Han and Se Hoon Park and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Taekyu Lim

14 papers receiving 458 citations

Peers

Countries citing papers authored by Taekyu Lim

Since Specialization

Citations

This map shows the geographic impact of Taekyu Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taekyu Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taekyu Lim more than expected).

Fields of papers citing papers by Taekyu Lim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taekyu Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taekyu Lim. The network helps show where Taekyu Lim may publish in the future.

Co-authorship network of co-authors of Taekyu Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Taekyu Lim. A scholar is included among the top collaborators of Taekyu Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taekyu Lim. Taekyu Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Human mesenchymal stem cells derived from umbilical cord and bone marrow exert immunomodulatory effects in different mechanisms 2020 ·World Journal of Stem Cells ·(unknown), Jung-Yeon Lim, Taekyu Lim, Keon-Il Im, Nayoun Kim, Young-Sun Nam, Young‐Woo Jeon, (unknown), Hyun Sun Ko, In Yang Park, Seok‐Goo Cho	25
2	Long Term Complete Response of Unresectable Locally Advanced Pancreatic Cancer after CCRT and Gemcitabine Chemotherapy 2016 ·(unknown), Taekyu Lim, (unknown), (unknown), Sang‐Hee Lee, (unknown), Ji‐Won Lee, (unknown)	1
3	Synergistic Effect of Simvastatin Plus Radiation in Gastric Cancer and Colorectal Cancer: Implications of BIRC5 and Connective Tissue Growth Factor 2015 ·International Journal of Radiation OncologyBiologyPhysics ·Taekyu Lim, In‐Kyoung Lee, Jungmin Kim, Won Ki Kang	25
4	Synergistic effect of simvastatin plus radiation in gastric cancer and colorectal cancer: Implications of BIRC5 and connective tissue growth factor. 2015 ·Journal of Clinical Oncology ·Taekyu Lim, Won Ki Kang	1
5	ALK inhibitor crizotinib combined with intrathecal methotrexate treatment for non-small cell lung cancer with leptomeningeal carcinomatosis 2012 ·Lung Cancer ·Hee Kyung Ahn, Boram Han, Su Jin Lee, Taekyu Lim, Jong‐Mu Sun, Jin Seok Ahn, Myung‐Ju Ahn, Keunchil Park	26
6	High-Dose Ifosfamide as Second- or Third-Line Chemotherapy in Refractory Bone and Soft Tissue Sarcoma Patients 2011 ·Oncology ·Soo Hyun Lee, Myung Hee Chang, Kyung Kee Baek, Boram Han, Taekyu Lim, Jeeyun Lee, Joon Oh Park	26
7	Primary CNS lymphoma other than DLBCL: a descriptive analysis of clinical features and treatment outcomes 2011 ·Annals of Hematology ·Taekyu Lim, Seok Jin Kim, Kihyun Kım, Jung-Il Lee, Do Hoon Lim, (unknown), Kyung Kee Baek, Ha Yeon Lee, Boram Han, Ji Eun Uhm, Young Hyeh Ko, Won Seog Kim	45
8	Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer 2011 ·Cancer Chemotherapy and Pharmacology ·Taekyu Lim, Jeeyun Lee, (unknown), Ha Yeon Lee, Boram Han, Kyung Kee Baek, Hee Kyung Ahn, Su Jin Lee, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Kyoung‐Mee Kim, Won Ki Kang	30
9	Gastroenteropancreatic neuroendocrine tumors: Incidence and treatment outcome in a single institution in Korea 2011 ·Asia-Pacific Journal of Clinical Oncology ·Taekyu Lim, Yong‐Seok Jee, Jae J. Kim, (unknown), Kyu Taek Lee, Young Ho Kim, (unknown), Sung Hoon Kim, Tae Sung Sohn, Dong Wook Choi, Seong‐Ho Choi, Ho-Kyung Chun, Woo Young Lee, (unknown), Kee‐Taek Jang, Young Suk Park	25
10	Impact of KRAS Mutations on Clinical Outcomes in Pancreatic Cancer Patients Treated with First-line Gemcitabine-Based Chemotherapy 2011 ·Molecular Cancer Therapeutics ·Seung Tae Kim, Do Hyoung Lim, Kee‐Taek Jang, Taekyu Lim, Yong‐Seok Jee, Yoon‐La Choi, (unknown), Jun Ho Yi, Kyung Kee Baek, Se Hoon Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Joon Oh Park	120
11	Clinical presentation of carcinoma of unknown primary: 14 years of experience 2010 ·Tumor Biology ·Jun Ho Yi, Yoon‐La Choi, Su Jin Lee, Hee Kyung Ahn, Kyung Kee Baek, Taekyu Lim, (unknown), Bo Han, Ha Yeon Lee, Hyun Jung Jun, Jeeyun Lee, Yeon Hee Park	2
12	Salvage S-1 monotherapy in metastatic colorectal cancer patients who failed irinotecan-based or oxaliplatin-based chemotherapy 2010 ·Medical Oncology ·(unknown), Jeeyun Lee, Ha Yeon Lee, Taekyu Lim, Su Jin Lee, Seong Yoon Yi, Se Hoon Park, Joon Oh Park, Ho Yeong Lim, Won Ki Kang, Young Suk Park	5
13	Impact of E2F-1 Expression on Clinical Outcome of Gastric Adenocarcinoma Patients with Adjuvant Chemoradiation Therapy 2008 ·Clinical Cancer Research ·Jeeyun Lee, Cheol Keun Park, Joon Oh Park, Taekyu Lim, Young Suk Park, Ho Yeong Lim, In‐Kyoung Lee, Tae Sung Sohn, Jae Hyung Noh, Jin Seok Heo, Sung Kim, Do Hoon Lim, Kyoung-Mee Kim, Won Ki Kang	35
14	Impact of epidermal growth factor receptor (EGFR) kinase mutations, EGFR gene amplifications, and KRAS mutations on survival of pancreatic adenocarcinoma 2007 ·Cancer ·Jeeyun Lee, Kee‐Taek Jang, Chang‐Seok Ki, Taekyu Lim, Young Suk Park, Ho Yeong Lim, (unknown), Won Ki Kang, Keunchil Park, Joon Oh Park	104

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact